Health News Releases

  • Today February 19
February 05, 2014 14:10
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis
TECFIDERA® (dimethyl fumarate) has been approved by the European Commission (EC) as a first-line oral treatment for people with relapsing-remitting multiple sclerosis (RRMS), the most common form of m
February 04, 2014 15:48
22nd Century Group Delivers Additional Proprietary Research Cigarettes with Various Nicotine Levels
22nd Century Group, Inc. (OTCQB: XXII, http://goo.gl/7CavNZ) today announced that Goodrich Tobacco Company, its wholly-owned subsidiary, has delivered an additional 5.5 million SPECTRUM® government re
January 28, 2014 17:15
LifeCell Corporation Acquires Advanced Adipose Tissue Injector
Kinetic Concepts, Inc. (KCI) announced today that LifeCell Corporation (LifeCell, www.lifecell.com/) has acquired an advanced adipose Tissue Injector (aTI) for improved fat grafting procedures from th
January 28, 2014 10:41
Quantum Biosystems Demonstrates First Reads Using Quantum Single Molecule Sequencing
Quantum Biosystems today announced the release of raw data access to its first reads. The company released reads showing an accuracy of more than 99% in non-homopolymer regions and homopolymer indels
January 27, 2014 20:00
AstraZeneca, DKFZ and EORTC Join WIN Consortium
The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine is proud to announce that AstraZeneca, DKFZ and EORTC have joined the Consortium. WIN is a unique global network of le
January 27, 2014 16:15
Catalent Files Registration Statement for Initial Public Offering
Catalent Pharma Solutions announced today that Catalent, Inc. has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public o
January 27, 2014 13:51
Saudi Arabian Medical Centers Select Vital as Its Enterprise Advanced Visualization Solution
Vital Images, Inc., a Toshiba Medical Systems Group Company and leading provider of advanced visualization and analysis solutions for healthcare providers, was selected by two leading university hospi
January 27, 2014 13:50
K2M Submits S-1 Draft Registration Statement for Proposed IPO
K2M Group Holdings, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 to the United States Securities and Exchange Commission (SEC) relating to the p
January 24, 2014 16:10
SecondOpinions.com, Featuring a State-of-the-Art Teleradiology and Telemedicine Platform, Introduces a New Global Feature Second Opinions Express TM
USARAD Holdings Inc, a leading US Joint Commission Accredited teleradiology and telemedicine solutions provider recently launched SecondOpinions.com which offers a state of the art, proprietary, web-b
January 16, 2014 08:25
KCI Negative Pressure Wound Therapy with Instillation Supplement Published in International Wound Journal
Kinetic Concepts, Inc. announced today the publication of a supplement, recently released in the International Wound Journal (IWJ), which outlines current wound care challenges and practices and prese
Dr Flavia Indrio
January 15, 2014 18:24
BioGaia: New Study Indicates It’s Possible to Prevent Colic in Healthy Infants
A study of 468 healthy newborns shows that infants given the probiotic Lactobacillus reuteri Protectis cried less than half as long as infants given a placebo. The infants given Lactobacillus reuteri
Jack Baker, Quintiles IT Security
January 15, 2014 17:00
Quintiles Receives Technology Security Award from IDG’s CSO Magazine
Quintiles(http://www.quintiles.com/news) announced today that it has been named to the 2014 CSO40 by IDG's CSO magazine for the second year in a row, recognizing its “Trusted Cloud Services Model” whi
January 14, 2014 17:35
Biotoscana agrees to acquire United Medical to expand commercial presence in Brazil and create a leading regional specialty pharmaceutical company in South America
Grupo Biotoscana SL, a pharmaceutical company based in Bogotá, Colombia, and majority owned by Advent International and Essex Woodlands, today announced that it has signed an agreement to acquire Unit
January 10, 2014 11:40
First International Consensus Guidelines Published for KCI Negative Pressure Wound Therapy with Instillation
Kinetic Concepts, Inc. (KCI) announced today the publication of the first International Consensus Guidelines for its Negative Pressure Wound Therapy with Instillation (NPWTi).[1] The guidelines appear
Information about potential adverse reactions from multiple medicines and a pill reminder are just s
January 09, 2014 16:50
Patients Get Safety Information, Pill Reminders with New Mobile App from Quintiles
Information about potential adverse reactions from multiple medicines and a pill reminder which can be set for hourly, daily or weekly alerts, are some of the features on a new mobile app created by Q
January 08, 2014 15:25
Quintiles’ Fourth Quarter 2013 Earnings Call Scheduled for Thursday, February 13th
Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the fourth quarter of 2013 prior to its investor call on Thursday, February 13, 2014, at 8 a.m. EST to discuss fo
January 08, 2014 10:51
Astellas to Form Strategic Partnership With ClearPath To Build Vaccine Portfolio
Astellas Pharma Inc. (Astellas) and ClearPath Development Company (ClearPath) announced today a strategic partnership to form a portfolio of development companies focused on vaccines targeting infecti
January 08, 2014 09:42
ABRAXANE® Plus gemcitabine Receives European Marketing Authorization for First-Line Treatment of Patients with Metastatic Pancreatic Cancer
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Commission (EC) has granted approval for ABRAXANE (paclitaxel formulated
January 07, 2014 12:55
GE To Expand in Life Sciences with Acquisition of Strategic Assets from Thermo Fisher Scientific
GE (NYSE:GE) and Thermo Fisher Scientific (NYSE:TMO) announced today that they have entered into an agreement for GE Healthcare to acquire Thermo Fisher’s HyClone™ cell culture media and sera, and gen
January 07, 2014 10:50
Quintiles Executive to Present at J.P. Morgan Healthcare Conference
Quintiles CEO Tom Pike will present at the 2014 J.P. Morgan Healthcare Conference on Wednesday, January 15, 2014 in San Francisco at the Westin St. Francis Hotel. The Quintiles presentation will b
December 26, 2013 09:10
Menicon, Azabu University, and Yokohama City University Identify the Glaucoma Susceptibility Gene SRBD1 in Dogs
Menicon announces that an article entitled, “Dogs and humans share a common susceptibility gene SRBD1 for glaucoma risk”, which presents the results of a study conducted by Menicon, Azabu University,
December 23, 2013 11:54
iHerb Wins 2013 Best International Business Mobile Website
iHerb.com, a leading online retailer of nutritional supplements and wellness products announced today that it won the 2013 Best International Business Mobile Website from The Web Marketing Association
December 23, 2013 10:18
First-in-Man Implantation of CARMAT’s Bioprosthetic Artificial Heart
CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart project, providing an alternative for people suffering from end-stage heart f
December 19, 2013 10:33
Octapharma Phase II/III trial for the targeted treatment of relapsing multiple sclerosis enrols first patients
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsi
December 18, 2013 14:31
Richard Relyea Elected to the Quintiles Transnational Holdings Inc. Board of Directors
Quintiles announced today that Mr. Richard Relyea has been elected to its board of directors. Mr. Relyea was designated by equity investor 3i to fill a vacancy on the Quintiles Transnational Holdin
25 per page50 per page75 per page100 per page